Home LiteratureArticle Details
PMID: 16759092 Published · ppublish English Journal Article

Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.

Journal of medicinal chemistry ·Vol. 49 ·No. 12 ·2006-06-15 ·Pages 3496-500

Klinger AL, McComsey DF, Smith-Swintosky V, Shank RP, Maryanoff BE

Abstract

This paper examines the relative effectiveness of bioisosteric sulfamate and sulfamide derivatives for inhibition of human carbonic anhydrase-II (CA-II) by using a direct binding assay based on the ThermoFluor method (Matulis et al. Biochemistry 2005, 44, 5258). Compounds 1-10, which represent five cognate sulfamate/sulfamide pairs, were studied by ThermoFluor to obtain binding affinities (K(a) values). The corresponding dissociation constants, K(d), provide an independent measure of CA-II activity relative to commonly used K(i) values from enzyme kinetics studies. There was a sizable difference in potency between the sulfamates and sulfamides, with the sulfamides being much less potent, by factors ranging from 25 (7/8) to 1,200 (3/4). These results are consistent with our recent report that sulfamides tend to be much weaker inhibitors of CA-II than their corresponding sulfamates (Maryanoff et al. J. Med. Chem. 2005, 48, 1941). Additionally, for arylsulfamides 10-12 the K(d) values determined by ThermoFluor and the K(i) values determined from enzyme kinetics are consistent. It appears that the sulfamide group is less suitable than the sulfamate group for obtaining potent inhibition of CA-II.

MeSH Terms
Carbonic Anhydrase II/antagonists & inhibitors,chemistry Carbonic Anhydrase Inhibitors/chemistry Dioxolanes/chemistry Humans Kinetics Protein Binding Structure-Activity Relationship Sulfonamides/chemistry Sulfonic Acids/chemistry Thermodynamics
Chemicals
Carbonic Anhydrase Inhibitors Dioxolanes Sulfonamides Sulfonic Acids sulfamic acid Carbonic Anhydrase II
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Klinger Alexandra L
Research & Early Development, Johnson & Johnson Pharmaceutical Research & Development, Spring House, Pennsylvania 19477-0776, USA.
McComsey David F
Smith-Swintosky Virginia
Shank Richard P
Maryanoff Bruce E
Article Info
Journal
Journal of medicinal chemistry
Abbr.
J Med Chem
ISSN
0022-2623
Published
2006-06-15
Pages
3496-500
Language
English
Region
United States
NLM ID
9716531
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com